Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice

British Journal of Pharmacology

Volumn 133, Issue 7, 2001, Pages 1005-1012

  Chiwata, Tsuyoshi ^a   Aragane, Katsumi ^a   Fujinami, Koji ^a   Kojima, Kazuhiro ^a   Ishibashi, Shun ^b   Yamada, Nobuhiro ^c   Kusunoki, Jun ^a  

^a FUJIREBIO INC   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ACAT; ACAT inhibitor; Apolipoprotein E; Atherosclerosis; F 1394; Foam cells; Knockout mouse; Low density lipoprotein receptor; Macrophages; Smooth muscle cells

Indexed keywords

3 [N (2,2,5,5 TETRAMETHYL 1,3 DIOXANE 4 CARBONYL)AMINO]PROPIONIC ACID 2 (3 NEOPENTYL 3 NONYLUREIDO)CYCLOHEXYL ESTER; APOLIPOPROTEIN E; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; DIACYLGLYCEROL ACYLTRANSFERASE; LOW DENSITY LIPOPROTEIN RECEPTOR; OIL SCARLET;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FOAM CELL; KNOCKOUT MOUSE; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0034891581     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704160     Document Type: Article

References (37)

1. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1
2. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: Possible role of hepatic ACAT in very low density lipoprotein secretion
3. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
4. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
5. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig
6. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation
7. Atherosclerosis, vascular remodeling, and impairment of endothelium- dependent relaxation in genetically altered hyperlipidemic mice
8. Mouse models of atherosclerosis
9. Cardiovascular disease burden increases, NIH funding decreases
10. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
11. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
12. Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995
13. Coronary plaque disruption
14. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
15. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
16. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections
17. Collagen quantitation by video-microdensitometry in rabbit atherosclerosis
18. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
19. Hypocholesterolemic action and prevention of cholesterol absorption via the gut by F-1394, a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, in cholesterol diet-fed rats
20. Studies on acyl-CoA:cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative
21. Molecular bases of the acute coronary syndromes
22. ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms
23. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall
24. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages
25. Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats
26. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
27. The ACAT inhibitor, C1-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters
28. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
29. Atherosclerosis - An inflammatory disease
30. Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents
31. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits
32. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
33. Gene expression of acyl coenzyme A:cholesterol acyltransferase is upregulated in human monocytes during differentiation and foam cell formation
34. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
35. Role of oxidized low density lipoprotein in atherogenesis
36. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia
37. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E